Periodic Reporting for period 3 - 3TR (Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions)
Okres sprawozdawczy: 2022-09-01 do 2024-02-29
These studies will help to improve the approaches to personalized medicine by arming frontline healthcare providers with more information to place patients on the right treatment at the right time. This will reduce the severity and damage of the disease by choosing the best treatment option right from the start. In consequence, the results of 3TR will reduce the costs of pharmacotherapy and the burden of a suboptimal treatment by helping to avoid them.
Finally, the results of this project will offer economic opportunities to European companies to exploit those results e.g. for the development of biomarker test kits. 3TR will therefore have an important social and economic impact in Europe.